Cargando…
The p47phox mouse knock-out model of chronic granulomatous disease
Chronic granulomatous disease (CGD) is caused by a congenital defect in phagocyte reduced nicotinamide dinucleotide phosphate (NADPH) oxidase production of superoxide and related species. It is characterized by recurrent life-threatening bacterial and fungal infections and tissue granuloma formation...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1995
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2192153/ https://www.ncbi.nlm.nih.gov/pubmed/7650482 |
Ejemplares similares
-
Novel Diagnostic Tool for p47(phox)-Deficient Chronic Granulomatous Disease Patient and Carrier Detection
por: Wrona, Dominik, et al.
Publicado: (2019) -
Lentiviral gene therapy rescues p47(phox) chronic granulomatous disease and the ability to fight Salmonella infection in mice
por: Schejtman, Andrea, et al.
Publicado: (2020) -
Preclinical Optimization and Safety Studies of a New Lentiviral Gene Therapy for p47(phox)-Deficient Chronic Granulomatous Disease
por: Schejtman, Andrea, et al.
Publicado: (2021) -
CRISPR/Cas9-generated p47(phox)-deficient cell line for Chronic Granulomatous Disease gene therapy vector development
por: Wrona, Dominik, et al.
Publicado: (2017) -
Pioglitazone Inhibits the Expressions of p22(phox) and p47(phox) in Rat Mesangial Cells In Vitro
por: Wang, Shan, et al.
Publicado: (2014)